Your browser doesn't support javascript.
loading
Obesity-Induced Coronary Microvascular Disease Is Prevented by iNOS Deletion and Reversed by iNOS Inhibition.
Shah, Soham A; Reagan, Claire E; Bresticker, Julia E; Wolpe, Abigail G; Good, Miranda E; Macal, Edgar H; Billcheck, Helen O; Bradley, Leigh A; French, Brent A; Isakson, Brant E; Wolf, Matthew J; Epstein, Frederick H.
Afiliação
  • Shah SA; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.
  • Reagan CE; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.
  • Bresticker JE; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.
  • Wolpe AG; The Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia, USA.
  • Good ME; The Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia, USA.
  • Macal EH; The Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia, USA.
  • Billcheck HO; Department of Cardiovascular Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • Bradley LA; Department of Cardiovascular Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • French BA; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.
  • Isakson BE; Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.
  • Wolf MJ; The Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia, USA.
  • Epstein FH; Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.
JACC Basic Transl Sci ; 8(5): 501-514, 2023 May.
Article em En | MEDLINE | ID: mdl-37325396
ABSTRACT
Coronary microvascular disease (CMD) caused by obesity and diabetes is major contributor to heart failure with preserved ejection fraction; however, the mechanisms underlying CMD are not well understood. Using cardiac magnetic resonance applied to mice fed a high-fat, high-sucrose diet as a model of CMD, we elucidated the role of inducible nitric oxide synthase (iNOS) and 1400W, an iNOS antagonist, in CMD. Global iNOS deletion prevented CMD along with the associated oxidative stress and diastolic and subclinical systolic dysfunction. The 1400W treatment reversed established CMD and oxidative stress and preserved systolic/diastolic function in mice fed a high-fat, high-sucrose diet. Thus, iNOS may represent a therapeutic target for CMD.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article